Basic Information
LncRNA/CircRNA Name | OIP5-AS1 |
Synonyms | Opa-interacting protein 5 antisense RNA 1 |
Region | GRCh38_15:41283990-41309737 |
Ensemble | ENSG00000247556 |
Refseq | NR_026757 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | Oxaliplatin | |
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colon cancer |
ICD-0-3 | C18 |
Methods | Western blot, Luciferase reporter assay etc. |
Sample | tumor tissues and corresponding normal tumor-adjacent tissues,Human CC cell lines (HCT116, LOVO, HT29, and SW480), and a human normal colon epithelial cell line (FHC) |
Expression Pattern | up-regulated |
Function Description | OIP5-AS1 was up-regulated in CC tissues and cells, while miR-137 was down-regulated in CC tissues and cells. OIP5-AS1 was inversely correlated with miR-137 (P < 0.001). Silencing OIP5-AS1 expression significantly hindered the proliferation, invasion and migration abilities of CC cells and markedly increased the apoptosis rate. Up-regulation of miR-137 expression also suppressed these abilities in CC cells and increased the apoptosis rate. Moreover, silencing OIP5-AS1 and up-regulating miR-137 expression significantly intensified growth inhibition of drug-resistant CC cells and improved the sensitivity of CC cells to L-OHP. |
Pubmed ID | 32308348 |
Year | 2020 |
Title | Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137. |
External Links
Links for OIP5-AS1 | GenBank HGNC NONCODE |
Links for colon cancer | OMIM COSMIC |